Get startedLog in
    Picture of Solara Active Pharma Sciences logo

    SOLARA — Solara Active Pharma Sciences News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: India's Solara Active Pharma Sciences Reports Sept-Quarter Consol Net Loss

    Picture of Solara Active Pharma Sciences logoSolara Active Pharma Sciences
    09/11/2022 07:59
    Nov 9 (Reuters) - Solara Active Pharma Sciences Ltd  SOLA.NS :
    * INDIA'S SOLARA ACTIVE PHARMA SCIENCES LTD SEPT-QUARTER CONSOL NET LOSS
99.6
MILLION RUPEES VERSUS PROFIT 297.1 MILLION RUPEES
    * SOLARA ACTIVE PHARMA SCIENCES LTD SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS
3.38 BILLION RUPEES VERSUS 4.02 BILLION RUPEES
    * SOLARA ACTIVE PHARMA SCIENCES LTD - VIZAG FACILITY RECEIVES CEP FOR
IBUPROFEN
MANUFACTURING COMMERCIAL PRODUCTION TO  COMMENCE IN Q3’23

Source text for Eikon:  ID:nNSE2ky34B 
Further company coverage:  SOLA.NS 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Solara Active Pharma Sciences

    See all news